Stephen H. Sands - Feb 22, 2022 Form 3 Insider Report for Cyteir Therapeutics, Inc. (CYT)

Role
Director
Signature
/s/ Andrew Gengos, Attorney-in-Fact
Stock symbol
CYT
Transactions as of
Feb 22, 2022
Transactions value $
$0
Form type
3
Date filed
2/24/2022, 03:49 PM
Next filing
Feb 7, 2023

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney